257 related articles for article (PubMed ID: 21118496)
21. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
Wang JZ; Fu X; Fang Z; Liu H; Zong FY; Zhu H; Yu YF; Zhang XY; Wang SF; Huang Y; Hui J
J Mol Cell Biol; 2021 Aug; 13(5):347-360. PubMed ID: 33196842
[TBL] [Abstract][Full Text] [Related]
22. Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis.
Whistler T; Chiang CF; Lonergan W; Hollier M; Unger ER
BMC Genomics; 2010 Sep; 11():496. PubMed ID: 20840771
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.
Valletti A; Gigante M; Palumbo O; Carella M; Divella C; Sbisà E; Tullo A; Picardi E; D'Erchia AM; Battaglia M; Gesualdo L; Pesole G; Ranieri E
PLoS One; 2013; 8(10):e78452. PubMed ID: 24194935
[TBL] [Abstract][Full Text] [Related]
24. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
25. Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.
Renshaw J; Orr RM; Walton MI; Te Poele R; Williams RD; Wancewicz EV; Monia BP; Workman P; Pritchard-Jones K
Mol Cancer Ther; 2004 Nov; 3(11):1467-84. PubMed ID: 15542786
[TBL] [Abstract][Full Text] [Related]
26. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
Lung Cancer; 2016 Feb; 92():41-6. PubMed ID: 26775595
[TBL] [Abstract][Full Text] [Related]
27. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
Thorsen K; Sørensen KD; Brems-Eskildsen AS; Modin C; Gaustadnes M; Hein AM; Kruhøffer M; Laurberg S; Borre M; Wang K; Brunak S; Krainer AR; Tørring N; Dyrskjøt L; Andersen CL; Orntoft TF
Mol Cell Proteomics; 2008 Jul; 7(7):1214-24. PubMed ID: 18353764
[TBL] [Abstract][Full Text] [Related]
29. High resolution analysis of the human transcriptome: detection of extensive alternative splicing independent of transcriptional activity.
Zhou W; Calciano MA; Jordan H; Brenner M; Johnson S; Wu D; Lei L; Pallares D; Beurdeley P; Rouet F; Gill PS; Bracco L; Soucaille C; Einstein R
BMC Genet; 2009 Oct; 10():63. PubMed ID: 19804644
[TBL] [Abstract][Full Text] [Related]
30. Exon-level microarray analyses identify alternative splicing programs in breast cancer.
Lapuk A; Marr H; Jakkula L; Pedro H; Bhattacharya S; Purdom E; Hu Z; Simpson K; Pachter L; Durinck S; Wang N; Parvin B; Fontenay G; Speed T; Garbe J; Stampfer M; Bayandorian H; Dorton S; Clark TA; Schweitzer A; Wyrobek A; Feiler H; Spellman P; Conboy J; Gray JW
Mol Cancer Res; 2010 Jul; 8(7):961-74. PubMed ID: 20605923
[TBL] [Abstract][Full Text] [Related]
31. Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays.
Kechris K; Yang YH; Yeh RF
BMC Genomics; 2008 Nov; 9():551. PubMed ID: 19021909
[TBL] [Abstract][Full Text] [Related]
32. A cross-platform comparison of genome-wide expression changes of laser microdissected lung tissue of C-Raf transgenic mice using 3'IVT and exon array.
Londhe KB; Borlak J
PLoS One; 2012; 7(7):e40778. PubMed ID: 22815814
[TBL] [Abstract][Full Text] [Related]
33. Gene expression and isoform variation analysis using Affymetrix Exon Arrays.
Bemmo A; Benovoy D; Kwan T; Gaffney DJ; Jensen RV; Majewski J
BMC Genomics; 2008 Nov; 9():529. PubMed ID: 18990248
[TBL] [Abstract][Full Text] [Related]
34. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
de Miguel FJ; Pajares MJ; Martínez-Terroba E; Ajona D; Morales X; Sharma RD; Pardo FJ; Rouzaut A; Rubio A; Montuenga LM; Pio R
Mol Oncol; 2016 Nov; 10(9):1437-1449. PubMed ID: 27555542
[TBL] [Abstract][Full Text] [Related]
35. Exon expression and alternatively spliced genes in Tourette Syndrome.
Tian Y; Liao IH; Zhan X; Gunther JR; Ander BP; Liu D; Lit L; Jickling GC; Corbett BA; Bos-Veneman NG; Hoekstra PJ; Sharp FR
Am J Med Genet B Neuropsychiatr Genet; 2011 Jan; 156B(1):72-8. PubMed ID: 21184586
[TBL] [Abstract][Full Text] [Related]
36. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
37. REMAS: a new regression model to identify alternative splicing events from exon array data.
Zheng H; Hang X; Zhu J; Qian M; Qu W; Zhang C; Deng M
BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S18. PubMed ID: 19208117
[TBL] [Abstract][Full Text] [Related]
38. 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.
Baty F; Joerger M; Früh M; Klingbiel D; Zappa F; Brutsche M
J Transl Med; 2017 Mar; 15(1):66. PubMed ID: 28359318
[TBL] [Abstract][Full Text] [Related]
39. A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.
Raghavachari N; Barb J; Yang Y; Liu P; Woodhouse K; Levy D; O'Donnell CJ; Munson PJ; Kato GJ
BMC Med Genomics; 2012 Jun; 5():28. PubMed ID: 22747986
[TBL] [Abstract][Full Text] [Related]
40. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
